市场调查报告书
商品编码
1159195
Rivastigmine经皮吸收贴片的全球市场(2022年~2028年)Rivastigmine Transdermal Patches Market 2022-2028 |
全球Rivastigmine经皮吸收贴片的市场规模在预测期间内预计将以6.5%的年复合成长率成长。推动市场成长的主要因素有其用于治疗与帕金森病和阿尔茨海默病相关的痴呆症、与其他给药途径相比的显着优势、低成本和药物依从性。例如,它对患者较少的患者很方便等。
本报告提供全球Rivastigmine经皮吸收贴片市场调查,提供市场概要,市场的推动因素与阻碍因素的分析,市场机会,各市场区隔,各地区的市场分析,主要企业的简介等系统性资讯。
Global Rivastigmine Transdermal Patches Market Size, Share & Trends Analysis Report, By Type (4.6mg/24hr, 9.5mg/24hr, and 13.3 mg/24hr), By Application (Alzheimer's Disease, Parkinson's Disease, and Others), Forecast Period (2022-2028)
The global rivastigmine transdermal patches market is anticipated to grow at a CAGR of 6.5% during the forecast period. Rivastigmine transdermal patches are used for the treatment of dementia-related to Parkinson's disease and Alzheimer's diseases with mild, moderate, and severe symptoms. Innovations in transdermal delivery systems contributed to medical practice by providing advances in the delivery of treatment with existing and novel drugs. Transdermal delivery systems have significant advantages over other routes of administration. It is used as a non-invasive, painless technique allowing less frequent or one-time dosing application in comparison to oral and other routes of administration. It reduces the gastrointestinal side-effects, enhances the therapeutic efficacy, and avoids the problem associated with a drug's toxicity, and drug formulation problems. Further, the rivastigmine transdermal patches are inexpensive and convenient for patients with fewer adherences to medications as it allows the maintenance of drug plasma levels due to consistent infusion and bioavailability of the drug. All these factors are driving the global rivastigmine transdermal patches market. Further, the continuous innovation and launches of rivastigmine transdermal patches are anticipated to boost market growth. For instance, in March 2019, Amneal Pharmaceuticals announced that it has launched its generic version of the rivastigmine transdermal system, 4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours. The Company received FDA approval for its rivastigmine transdermal System in January 2019.
The global rivastigmine transdermal patches market is segmented based on the type and application. Based on the type, the market is segmented into 4.6mg/24hr, 9.5mg/24hr, and 13.3 mg/24hr. Based on the application, the market is segmented into Alzheimer's disease, Parkinson's disease, and others. Based on type 9.5mg/24hr segment is anticipated to hold the dominant share in the market during the forecast period. High adherence to medication in patients, fewer side effects, and high efficacy of the medicine is the prime factor for the growth of the segment in the market.
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the dominant share in the market due to the existence of key companies in the region. Growing R&D and the launch of innovative techniques to deliver medicine are factors driving the market in the region. However, the Asia-Pacific region is anticipated to register the highest growth in the market during the forecast period owing to the expansion of pharmaceutical companies and awareness about neurological diseases among the population are some key factors driving the market in the region.
The major companies serving the global rivastigmine transdermal patches market include Amneal Pharmaceuticals Inc., Luye Pharma Group, Novartis International AG, Ono Pharmaceutical Co., Ltd., and Zydus Healthcare Ltd. The market players are contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2021, Luye Pharma Group announced the successful completion of the Decentralized Registration Procedures (DCPs) for its Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD).
Research Methodology
The market study of the global rivastigmine transdermal patches market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: